Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Libya's healthcare crisis has a sad, new face. It is that of a tired 7-year-old girl, Sohan Aboulsoud, who suffers from ...

ECMO use in cystic fibrosis with severe respiratory failure showed limited survival, highlighting the need for cautious ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

Chronic colonization by filamentous fungi in patients with cystic fibrosis (pwCF) is linked to declines in lung function and quality of life. To better assess indoor mold exposure, 23 French dwellings ...

Most children with CF treated at a San Francisco CF clinic did not receive CF liver disease screening in accordance with current guidelines.

Passage of the bill — which cuts critical health coverage for people with cystic fibrosis and their families — shows the ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...

VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years ...

The community is rallying to help a young Gold Coast woman who lives with cystic fibrosis and is in the fight of her life ...

A 7-year-old girl with cystic fibrosis recently became a symbol of Libya's healthcare crisis. Her family undertook an illicit journey to Italy to get her the care their own country didn't provide.

Two brothers and two friends take on and wi, an 80-mile Atlantic paddleboard challenge in an effort to provide support for ...